CDK 4/6 Inhibitors in HR+/HER2- Breast Cancer – Jamaica, NY
NYC Health + Hospitals/Queens 82-68 164th Street Main-bldg, 5th Floor, Conference Room A540, Jamaica, NY, United StatesThis program will review the use of CDK 4/6 inhibitors in the treatment of HR+/HER2-negative breast cancer and the management of treatment-related adverse events.